[PDF] Guideline 155: Pharmacological management of migraine - Full guideline

Source:
Scottish Intercollegiate Guidelines Network - SIGN
Publisher:
Scottish Intercollegiate Guidelines Network (SIGN)
Publication date:
01 February 2018

Abstract

(2018) Guideline 155: Pharmacological management of migraine - Full guideline. The Scottish Intercollegiate Guidelines Network (SIGN) develops evidence based clinical practice guidelines for the National Health Service (NHS) in Scotland. SIGN guidelines are derived from a systematic review of the scientific literature and are designed as a vehicle for accelerating the translation of new knowledge into action to meet our aim of reducing variations in practice, and improving patient-important outcomes.

This guideline provides recommendations on the pharmacological management of adults with acute migraine, and prophylaxis for patients with episodic or chronic migraine or medication overuse headache.